Identity
- Security key
- 14826
- Ticker
- ENVB
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 1995-08-24
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- ENVB
Detail
Enriched 2026-08-14 20:47
- Market cap
- $6,244,139.35
- Shares outstanding (class)
- 3,681,884
- Shares outstanding (weighted)
- 4,028,477
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 6
- Location
- CAMBRIDGE, MA
- Homepage
- https://www.enveric.com
- Description
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.